Incidence of new-onset atrial fibrillation after cavotricuspid isthmus ablation for isolated typical atrial flutter: a systematic review and meta-analysis

Back

EHRA Premium Access

Incidence of new-onset atrial fibrillation after cavotricuspid isthmus ablation for isolated typical atrial flutter: a systematic review and meta-analysis

Session: Treatment of atrial fibrillation and stroke prevention

Topic: Stroke Prevention

Speaker: Doctor A. Griffin (Adelaide, AU)

Event: EHRA 2021

Congress Presentation

Add to my library

About the speaker

Doctor Andrew Griffin

Royal Adelaide Hospital, Adelaide (Australia)

0 follower

6 more presentations in this session

Incidence and location of residual gaps identified by a high-density grid-style catheter after PVI is confirmed by pacing the ablation lines

Speaker: Doctor S. Sundaram (Littleton, US)

Catheter ablation outscores all other treatment modalities in reducing all-cause mortality and heart failure related morbidity in patients of persistent atrial fibrillation with systolic heart failure

Speaker: Doctor D. Khanra (CHESTER, GB)

Efficacy and safety of a high power short duration ablation-index guided protocol for pulmonary vein isolation using a single catheter

Speaker: Doctor P. Badertscher (Basel, CH)

Shorter interlesion distance is associated with a longer procedure time but not with poorer acute results of pulmonary vein isolation: results from a prospective ablation index registry

Speaker: Doctor N. Gasimova (Saint Petersburg, RU)

Is the optimal blanking period duration after cryoballoon pulmonary vein isolation impacted by use of antiarrhythmic drugs?

Speaker: Doctor D. Musat (Ridgewood, US)

Access the full session

Treatment of atrial fibrillation and stroke prevention

Speakers: Doctor A. Griffin, Doctor S. Sundaram, Doctor D. Khanra, Doctor P. Badertscher, Doctor N. Gasimova...

Access

About the event

EHRA 2021

23 April - 25 April 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources